INTERNATIONAL PATENT: JANSSEN BIOTECH, INC. FILES APPLICATION FOR "METHODS FOR REDUCING DERMATOLOGIC ADVERSE EVENTS IN PATIENTS TREATED WITH EGFR/MET BISPECIFIC ANTIBODIES"

GENEVA, Feb. 23 -- JANSSEN BIOTECH, INC. (800/850 Ridgeview DriveHorsham, Pennsylvania 19044) filed a patent application (PCT/IB2025/058234) for "METHODS FOR REDUCING DERMATOLOGIC ADVERSE EVENTS IN PATIENTS TREATED WITH EGFR/MET BISPECIFIC ANTIBODIES" on Aug 13, 2025. With publication no. WO/2026/038161, the details related to the patent application was published on Feb 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SIMOES, Jairo Amorim (920 US Highway 202Raritan, New Jersey 08869), MAHADEVIA, Parthiv (430 US Highway 22 EBridgewater, New Jersey 08807), NEMATIAN-SAMANI, Mehregan (920 US ...